Indoleamine 2,3-Dioxygenase Related Metabolic Effects of 3-Aminobenzamide and Infliximab in Lung Tissue of Experimental Colitis Model

dc.contributor.authorSahin, D.
dc.contributor.authorDincel, A. Sepici
dc.contributor.authorAkca, G.
dc.contributor.authorOzkan, Y.
dc.contributor.authorMenekse, E.
dc.contributor.authorDolapci, M.
dc.date.accessioned2023-12-14T10:03:38Z
dc.date.available2023-12-14T10:03:38Z
dc.date.issued2015
dc.identifier.eissn1742-4658en_US
dc.identifier.endpage279en_US
dc.identifier.issn1742-464Xen_US
dc.identifier.issueSupplement 1en_US
dc.identifier.startpage279en_US
dc.identifier.urihttp://hdl.handle.net/11727/11096
dc.identifier.volume282en_US
dc.identifier.wos000362570605055en_US
dc.language.isoengen_US
dc.relation.journalFEBS JOURNALen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIndoleamine 2,3-Dioxygenase Related Metabolic Effects of 3-Aminobenzamide and Infliximab in Lung Tissue of Experimental Colitis Modelen_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: